BAUSCH HEALTH COS INC

Investor‑alert: Bausch Health insider Lenar Aimee J. sold 36k shares at $7.03—profit‑taking after a 47% monthly rally. Watch for short‑term pullback and evaluate the company’s pipeline before investing.

Lenar Aimee J.’s insider sale at $4.89 amid a wave of Bausch Health divestments signals investor caution and may foreshadow sharper price moves.

Insider sale of 3,125 Bausch Health shares signals routine tax‑withholding, not a sell‑off, showing executive confidence amid a 23% price decline.

Investor insight: Amy Wechsler’s Bausch Health share buy signals confidence in its eye‑health and CNS pipeline, hinting at potential upside after upcoming milestones.

Lee Frank D’s Bausch Health sale is a routine tax‑planning move, not a bearish sign; insiders overall are buying, signaling confidence in the company’s prospects.

Insightful look at Bausch Health CFO’s recent insider sale: why it’s a liquidity move, not a bearish signal, and what it means for investors.

CEO Appio Thomas’s 1.1 M‑share performance‑based award shows strong confidence in Bausch Health’s 2025 targets and signals a bullish insider stance for value‑driven investors.